Maximize Your Chances of Success: Avoid and Mitigate Risk of Failure When Developing Biotherapeutics
Scientist
Date: March 10. Time: 4:00 PM CET.
Advancing your drug or vaccine candidate from late-stage discovery into the clinic is one of the most critical steps in development. This is the phase when you make key decisions that will have long-term scientific and business impact, frequently under extreme time and cost pressure. For example, developability and manufacturability issues can arise due to post-translational modifications and aggregation, and immunogenicity risks due to the presence of T-cell epitopes.